Skye Bioscience Inc.

Last updated September 27, 2026

Organization details

Legal name
Skye Bioscience Inc.
Ownership
Public
Status
Active
Headquarters country
United States
Ticker symbol
SKYE
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001516551

Board of directors

Chief executives

Punit Dhillon · Chief Executive Officer
Dates unknown

Board connections

4 of this board's directors also sit on 8 other boards.

Network of Skye Bioscience Inc.'s board connections Aurinia Pharmaceuticals Inc Aurinia Pharmaceutical... CAMP4 Therapeutics Corporation CAMP4 Therapeutics Cor... COMPASS Pathways Plc COMPASS Pathways Plc Context Therapeutics Inc. Context Therapeutics I... Enliven Therapeutics Inc. Enliven Therapeutics I... Kiora Pharmaceuticals Inc. Kiora Pharmaceuticals... Mereo BioPharma Group plc Mereo BioPharma Group... Tectonic Therapeutic Inc. Tectonic Therapeutic I... Andrew J. Schwab Andrew J. Schwab Annalisa Jenkins Annalisa Jenkins Karen L. Smith Karen L. Smith Praveen Tyle Praveen Tyle Skye Bioscience Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$889,204
30 sales by 2 insiders
Date Insider Transaction Shares Price Value
Sep 23, 2026 5AM Partners VII, LLC 10% owner Open-market sale −114,851 $1.61 $184,910
Sep 23, 2026 Andrew J. Schwab Director, 10% owner Open-market sale −114,851 $1.61 $184,910
Sep 23, 2026 5AM Partners VII, LLC 10% owner Open-market sale −4,528 $1.61 $7,290
Sep 23, 2026 Andrew J. Schwab Director, 10% owner Open-market sale −4,528 $1.61 $7,290
Sep 22, 2026 5AM Partners VII, LLC 10% owner Open-market sale −27,612 $1.65 $45,560
Sep 22, 2026 Andrew J. Schwab Director, 10% owner Open-market sale −27,612 $1.65 $45,560
Sep 22, 2026 5AM Partners VII, LLC 10% owner Open-market sale −1,088 $1.65 $1,795
Sep 22, 2026 Andrew J. Schwab Director, 10% owner Open-market sale −1,088 $1.65 $1,795
Sep 16, 2026 5AM Partners VII, LLC 10% owner Open-market sale −32,607 $1.91 $62,279
Sep 16, 2026 Andrew J. Schwab Director, 10% owner Open-market sale −32,607 $1.91 $62,279
Sep 16, 2026 5AM Partners VII, LLC 10% owner Open-market sale −1,285 $1.91 $2,454
Sep 16, 2026 Andrew J. Schwab Director, 10% owner Open-market sale −1,285 $1.91 $2,454
Aug 20, 2026 5AM Partners VII, LLC 10% owner Open-market sale −1,159 $0.32 $371
Aug 20, 2026 Andrew J. Schwab Director, 10% owner Open-market sale −1,159 $0.32 $371
Aug 20, 2026 5AM Partners VII, LLC 10% owner Open-market sale −46 $0.32 $15

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.